82 FR 37228 - Draft National Occupational Research Agenda for Cancer, Reproductive, Cardiovascular and Other Chronic Disease Prevention
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 152 (August 9, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 152 (August 9, 2017)
| Page Range | 37228-37229 | |
| FR Document | 2017-16801 |
[Federal Register Volume 82, Number 152 (Wednesday, August 9, 2017)] [Notices] [Pages 37228-37229] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-16801] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC-2017-0068, NIOSH-299] Draft National Occupational Research Agenda for Cancer, Reproductive, Cardiovascular and Other Chronic Disease Prevention AGENCY: National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for comments. ----------------------------------------------------------------------- SUMMARY: As steward of the National Occupational Research Agenda (NORA), the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention announces the availability of the draft National Occupational Research Agenda for Cancer, Reproductive, Cardiovascular and Other Chronic Disease Prevention Agenda for public comment. Written by the NORA Cancer, Reproductive, Cardiovascular and Other Chronic Disease Prevention Cross-Sector Council, the Agenda identifies the most important occupational safety and health research needs for the next decade, 2016-2026. A copy of the draft Agenda is available at http://www.regulations.gov (search Docket Number CDC-2017-0068). DATES: Electronic or written comments must be received by October 10, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC-2017- 0068 and docket number NIOSH-299, by any of the following methods:Federal eRulemaking Portal: http://www.regulations.gov. Follow the instructions for submitting comments. Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998. Instructions: All submissions received must include the agency name and Docket Number [CDC-2017-0068; NIOSH-299]. All relevant comments received will be posted without change to http://regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to http://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Emily Novicki ([email protected]), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E-20, 1600 Clifton Road NE., Atlanta, GA 30329. SUPPLEMENTARY INFORMATION: The National Occupational Research Agenda (NORA) is a partnership program created to stimulate innovative research and improved workplace practices. The national agenda is developed and implemented through the NORA sector and cross-sector councils. Each council develops and maintains an agenda for its sector or cross-sector. The National Occupational Research Agenda for Cancer, Reproductive, Cardiovascular and other Chronic Disease Prevention (CRC) is intended to identify the research, information, and actions most urgently needed to prevent occupational cancer, adverse reproductive outcomes and cardiovascular disease. The National Occupational Research Agenda for CRC provides a vehicle for industry stakeholders to describe the most relevant issues, gaps, and safety and health needs for the sector. It is meant to be broader than any one agency or organization. It is a strategic plan for the entire country and all of its research and development entities, whether government, higher education, or industry. This is the first CRC Agenda, developed for the third decade of NORA (2016-2026). The agenda was developed considering new information about injuries and illnesses, the state of the science, and the probability that new information and approaches will make a difference. [[Page 37229]] As the steward of the NORA process, NIOSH invites comments on the draft National Occupational Research Agenda for CRC. A copy of the draft Agenda is available at http://www.regulations.gov (see Docket Number CDC-2017-0068, NIOSH-299). John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2017-16801 Filed 8-8-17; 8:45 am] BILLING CODE 4163-18-P
![37228 Federal Register / Vol. 82, No. 152 / Wednesday, August 9, 2017 / Notices
OMB control number: 7100–NEW. collection of information on the FR DATES: Electronic or written comments
Frequency: Quantitative Survey, 3077. The FR 3077 is a voluntary must be received by October 10, 2017.
annually; Qualitative Survey, survey. ADDRESSES: You may submit comments,
occasionally. The ability of the Board to maintain identified by Docket No. CDC–2017–
Respondents: Consumers. the confidentiality of information
Estimated number of respondents: 0068 and docket number NIOSH–299,
provided by respondents to the FR 3077 by any of the following methods:
Quantitative Survey, 17,000 will have to be determined on a case-by-
respondents; Qualitative Survey, 30 • Federal eRulemaking Portal: http://
case basis depending on the type of www.regulations.gov. Follow the
respondents. information provided for a particular
Estimated average hours per response: instructions for submitting comments.
survey. To the extent that a respondent’s
Quantitative Survey, 0.47 hours; • Mail: National Institute for
answers reveal information ‘‘the
Qualitative Survey, 2 hours. Occupational Safety and Health, NIOSH
disclosure of which would constitute a
Estimated annual burden hours: Docket Office, 1090 Tusculum Avenue,
clearly unwarranted invasion of
Quantitative Survey, 7,990 hours; MS C–34, Cincinnati, Ohio 45226–1998.
personal privacy,’’ such information
Qualitative Survey, 180 hours. Instructions: All submissions received
would likely be exempt from disclosure
General description of report: The must include the agency name and
information collected could be used for under exemption 6 of the Freedom of
Information Act, (5 U.S.C. 552(b)(6)). Docket Number [CDC–2017–0068;
the Board’s Report on the Economic NIOSH–299]. All relevant comments
Well-Being of U.S. Households, for Consultation outside the agency: The
Board will consult with outside subject received will be posted without change
Board studies or working papers, to http://regulations.gov, including any
professional journals, the Federal matter experts for specific questions, as
needed. personal information provided. For
Reserve Bulletin, testimony and reports access to the docket to read background
to the Congress, or other vehicles. Such Board of Governors of the Federal Reserve documents or comments received, go to
event-driven consumer data collections System, August 4, 2017. http://www.regulations.gov.
could also be used to inform Board Margaret McCloskey Shanks,
FOR FURTHER INFORMATION CONTACT:
policy, regulatory, supervisory and Deputy Secretary of the Board.
Emily Novicki (NORACoordinator@
operational decisions. [FR Doc. 2017–16773 Filed 8–8–17; 8:45 am]
The Board anticipates that the SHED cdc.gov), National Institute for
BILLING CODE 6210–01–P Occupational Safety and Health, Centers
would include such topics as
individuals’ overall financial well- for Disease Control and Prevention,
being, employment experiences, income Mailstop E–20, 1600 Clifton Road NE.,
DEPARTMENT OF HEALTH AND Atlanta, GA 30329.
and savings behaviors, economic HUMAN SERVICES
preparedness, access to banking and SUPPLEMENTARY INFORMATION: The
credit, housing and living arrangement Centers for Disease Control and National Occupational Research Agenda
decisions, education and human capital, Prevention (NORA) is a partnership program
student loans, and retirement planning. created to stimulate innovative research
The overall content of the SHED [Docket No. CDC–2017–0068, NIOSH–299] and improved workplace practices. The
instrument would depend on changing national agenda is developed and
Draft National Occupational Research implemented through the NORA sector
economic, regulatory, or legislative Agenda for Cancer, Reproductive,
developments as well as changes in the and cross-sector councils. Each council
Cardiovascular and Other Chronic develops and maintains an agenda for
financial services industry. Disease Prevention
Legal authorization and its sector or cross-sector. The National
confidentiality: The Board’s Legal AGENCY: National Institute for Occupational Research Agenda for
Division has determined that Section 2A Occupational Safety and Health Cancer, Reproductive, Cardiovascular
of the Federal Reserve Act (FRA) (NIOSH), Centers for Disease Control and other Chronic Disease Prevention
requires that the Federal Reserve Board and Prevention (CDC), Department of (CRC) is intended to identify the
and the Federal Open Market Health and Human Services (HHS). research, information, and actions most
Committee maintain long run growth of ACTION: Request for comments. urgently needed to prevent occupational
the monetary and credit aggregates cancer, adverse reproductive outcomes
commensurate with the economy’s long SUMMARY: As steward of the National and cardiovascular disease. The
run potential to increase production, so Occupational Research Agenda (NORA), National Occupational Research Agenda
as to promote effectively the goals of the National Institute for Occupational for CRC provides a vehicle for industry
maximum employment, stable prices, Safety and Health of the Centers for stakeholders to describe the most
and moderate long-term interest rates Disease Control and Prevention relevant issues, gaps, and safety and
(12 U.S.C. 225a). Under section 12A of announces the availability of the draft health needs for the sector. It is meant
the FRA, the Federal Open Market National Occupational Research Agenda to be broader than any one agency or
Committee is required to implement for Cancer, Reproductive, organization. It is a strategic plan for the
regulations relating to the open market Cardiovascular and Other Chronic entire country and all of its research and
operations conducted by Federal Disease Prevention Agenda for public development entities, whether
Reserve Banks with a view to comment. Written by the NORA Cancer, government, higher education, or
accommodating commerce and business Reproductive, Cardiovascular and Other industry.
and with regard to their bearing upon Chronic Disease Prevention Cross-Sector This is the first CRC Agenda,
sradovich on DSK3GMQ082PROD with NOTICES
the general credit situation of the Council, the Agenda identifies the most developed for the third decade of NORA
country (12 U.S.C. 263). Because the important occupational safety and (2016–2026). The agenda was developed
Board and the Federal Open Market health research needs for the next considering new information about
Committee use the information obtained decade, 2016–2026. A copy of the draft injuries and illnesses, the state of the
on the FR 3077 to fulfill these Agenda is available at http:// science, and the probability that new
obligations, these statutory provisions www.regulations.gov (search Docket information and approaches will make a
provide the legal authorization for the Number CDC–2017–0068). difference.
VerDate Sep<11>2014 17:00 Aug 08, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1](https://thefederalregister.org/doc/82_FR_37380/page/1.svg)
![Federal Register / Vol. 82, No. 152 / Wednesday, August 9, 2017 / Notices 37229
As the steward of the NORA process, either electronic or written comments made publicly available, submit your
NIOSH invites comments on the draft on the draft guidance by October 10, comments only as a written/paper
National Occupational Research Agenda 2017. submission. You should submit two
for CRC. A copy of the draft Agenda is ADDRESSES: You may submit comments copies total. One copy will include the
available at http://www.regulations.gov as follows: information you claim to be confidential
(see Docket Number CDC–2017–0068, with a heading or cover note that states
NIOSH–299). Electronic Submissions ‘‘THIS DOCUMENT CONTAINS
Submit electronic comments in the CONFIDENTIAL INFORMATION.’’ The
John Howard,
following way: Agency will review this copy, including
Director, National Institute for Occupational the claimed confidential information, in
Safety and Health, Centers for Disease Control • Federal eRulemaking Portal:
and Prevention. https://www.regulations.gov. Follow the its consideration of comments. The
instructions for submitting comments. second copy, which will have the
[FR Doc. 2017–16801 Filed 8–8–17; 8:45 am]
Comments submitted electronically, claimed confidential information
BILLING CODE 4163–18–P
including attachments, to https:// redacted/blacked out, will be available
www.regulations.gov will be posted to for public viewing and posted on
DEPARTMENT OF HEALTH AND the docket unchanged. Because your https://www.regulations.gov. Submit
HUMAN SERVICES comment will be made public, you are both copies to the Dockets Management
solely responsible for ensuring that your Staff. If you do not wish your name and
Food and Drug Administration comment does not include any contact information to be made publicly
confidential information that you or a available, you can provide this
[Docket No. FDA–2017–D–0829] information on the cover sheet and not
third party may not wish to be posted,
such as medical information, your or in the body of your comments and you
Expiration Dating of Unit-Dose
anyone else’s Social Security number, or must identify this information as
Repackaged Solid Oral Dosage Form
confidential business information, such ‘‘confidential.’’ Any information marked
Drug Products; Revised Draft
as a manufacturing process. Please note as ‘‘confidential’’ will not be disclosed
Guidance for Industry; Availability
that if you include your name, contact except in accordance with 21 CFR 10.20
AGENCY: Food and Drug Administration, information, or other information that and other applicable disclosure law. For
HHS. identifies you in the body of your more information about FDA’s posting
ACTION: Notice of availability. comments, that information will be of comments to public dockets, see 80
posted on https://www.regulations.gov. FR 56469, September 18, 2015, or access
SUMMARY: The Food and Drug • If you want to submit a comment the information at: https://www.gpo.gov/
Administration (FDA or Agency) is with confidential information that you fdsys/pkg/FR-2015-09-18/pdf/2015-
announcing the availability of a revised do not wish to be made available to the 23389.pdf.
draft guidance for industry entitled public, submit the comment as a Docket: For access to the docket to
‘‘Expiration Dating of Unit-Dose written/paper submission and in the read background documents or the
Repackaged Solid Oral Dosage Form manner detailed (see ‘‘Written/Paper electronic and written/paper comments
Drug Products.’’ The last few decades Submissions’’ and ‘‘Instructions’’). received, go to https://
have seen an increasing demand in www.regulations.gov and insert the
various health care settings for solid oral Written/Paper Submissions docket number, found in brackets in the
dosage form drug products repackaged Submit written/paper submissions as heading of this document, into the
into unit-dose containers, which hold a follows: ‘‘Search’’ box and follow the prompts
quantity of drug for administration as a • Mail/Hand delivery/Courier (for and/or go to the Dockets Management
single dose. The increase in unit-dose written/paper submissions): Dockets Staff, 5630 Fishers Lane, Rm. 1061,
repackaging has led to questions Management Staff (HFA–305), Food and Rockville, MD 20852.
regarding stability studies and Drug Administration, 5630 Fishers Submit written requests for single
appropriate expiration dates for these Lane, Rm. 1061, Rockville, MD 20852. copies of the revised draft guidance to
repackaged products. This revised draft • For written/paper comments the Division of Drug Information, Center
guidance describes the conditions under submitted to the Dockets Management for Drug Evaluation and Research, Food
which FDA does not intend to take Staff, FDA will post your comment, as and Drug Administration, 10001 New
action regarding required stability well as any attachments, except for Hampshire Ave., Hillandale Building,
studies for these repackaged products information submitted, marked and 4th Floor, Silver Spring, MD 20993–
and the expiration date to assign under identified, as confidential, if submitted 0002. Send one self-addressed adhesive
those conditions. Through this notice, as detailed in ‘‘Instructions.’’ label to assist that office in processing
FDA is hoping to decrease the Instructions: All submissions received your requests. See the SUPPLEMENTARY
regulatory burdens of drug regulations must include the Docket No. FDA– INFORMATION section for electronic
on manufacturers of these products, 2017–D–0829 for ‘‘Expiration Dating of access to the revised draft guidance
while at the same time ensuring patient Unit-Dose Repackaged Solid Oral document.
safety. Since FDA’s guidance documents Dosage Form Drug Products.’’ Received FOR FURTHER INFORMATION CONTACT: Bill
do not bind the public or FDA to any comments will be placed in the docket Harvey, Center for Drug Evaluation and
requirements, they have not been and, except for those submitted as Research, Food and Drug
considered to be subject to Executive ‘‘Confidential Submissions,’’ publicly Administration, 10903 New Hampshire
sradovich on DSK3GMQ082PROD with NOTICES
Order 12866. viewable at https://www.regulations.gov Ave., Bldg. 51, Rm. 4214, Silver Spring,
DATES: Although you can comment on or at the Dockets Management Staff MD 20993–0002, 240–402–4180.
any guidance at any time (see 21 CFR between 9 a.m. and 4 p.m., Monday SUPPLEMENTARY INFORMATION:
10.115(g)(5)), to ensure that the Agency through Friday.
considers your comment on this revised • Confidential Submissions—To I. Background
draft guidance before it begins work on submit a comment with confidential FDA is announcing the availability of
the final version of the guidance, submit information that you do not wish to be a revised draft guidance for industry
VerDate Sep<11>2014 17:00 Aug 08, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1](https://thefederalregister.org/doc/82_FR_37380/page/2.svg)
Document Created: 2017-08-09 02:18:15
Document Modified: 2017-08-09 02:18:15
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Request for comments. | |
| Dates | Electronic or written comments must be received by October 10, 2017. | |
| Contact | Emily Novicki ([email protected]), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E-20, 1600 Clifton Road NE., Atlanta, GA 30329. | |
| FR Citation | 82 FR 37228 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR